Concepts (136)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteoarthritis, Knee | 6 | 2019 | 51 | 1.510 |
Why?
|
| Osteoarthritis | 8 | 2020 | 90 | 1.320 |
Why?
|
| Arthralgia | 3 | 2019 | 25 | 0.980 |
Why?
|
| Hyaluronic Acid | 2 | 2019 | 7 | 0.840 |
Why?
|
| Pain | 5 | 2017 | 47 | 0.760 |
Why?
|
| Humans | 23 | 2020 | 2957 | 0.670 |
Why?
|
| Nerve Growth Factor | 2 | 2017 | 11 | 0.650 |
Why?
|
| Nerve Growth Factors | 1 | 2020 | 3 | 0.630 |
Why?
|
| Musculoskeletal Pain | 1 | 2020 | 3 | 0.630 |
Why?
|
| Analgesics | 1 | 2020 | 20 | 0.620 |
Why?
|
| Lupus Erythematosus, Systemic | 6 | 2017 | 29 | 0.600 |
Why?
|
| Antibodies, Monoclonal | 1 | 2017 | 11 | 0.530 |
Why?
|
| Arthritis, Rheumatoid | 4 | 2020 | 26 | 0.520 |
Why?
|
| Knee Joint | 6 | 2011 | 43 | 0.470 |
Why?
|
| Gait | 5 | 2010 | 36 | 0.450 |
Why?
|
| Middle Aged | 14 | 2017 | 792 | 0.400 |
Why?
|
| Bone Density | 4 | 2006 | 79 | 0.400 |
Why?
|
| Analgesics, Non-Narcotic | 2 | 2017 | 8 | 0.400 |
Why?
|
| Female | 14 | 2017 | 1724 | 0.340 |
Why?
|
| Male | 13 | 2017 | 1860 | 0.320 |
Why?
|
| Synovial Fluid | 2 | 2011 | 23 | 0.320 |
Why?
|
| Quadriceps Muscle | 1 | 2010 | 4 | 0.320 |
Why?
|
| Knee | 1 | 2010 | 7 | 0.320 |
Why?
|
| Exercise Therapy | 1 | 2010 | 8 | 0.320 |
Why?
|
| Adult | 11 | 2017 | 794 | 0.310 |
Why?
|
| Rheumatology | 2 | 2020 | 10 | 0.310 |
Why?
|
| Treatment Outcome | 3 | 2019 | 186 | 0.280 |
Why?
|
| Arthritis, Experimental | 2 | 2019 | 25 | 0.270 |
Why?
|
| Aged | 7 | 2017 | 956 | 0.250 |
Why?
|
| Pain Management | 3 | 2018 | 27 | 0.240 |
Why?
|
| Keratan Sulfate | 1 | 2006 | 5 | 0.240 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2006 | 23 | 0.240 |
Why?
|
| Animals | 4 | 2020 | 1050 | 0.220 |
Why?
|
| Pain Measurement | 4 | 2018 | 54 | 0.210 |
Why?
|
| Hip Joint | 2 | 2000 | 38 | 0.190 |
Why?
|
| Rheumatologists | 2 | 2020 | 8 | 0.170 |
Why?
|
| Health Status | 3 | 2017 | 19 | 0.170 |
Why?
|
| Joints | 1 | 2001 | 15 | 0.160 |
Why?
|
| Antirheumatic Agents | 1 | 2020 | 8 | 0.160 |
Why?
|
| Chronic Pain | 1 | 2020 | 20 | 0.160 |
Why?
|
| Adjuvants, Immunologic | 1 | 2019 | 1 | 0.150 |
Why?
|
| Injections, Intra-Articular | 1 | 2019 | 7 | 0.150 |
Why?
|
| Azacitidine | 1 | 2019 | 6 | 0.150 |
Why?
|
| Enzyme Inhibitors | 1 | 2019 | 47 | 0.150 |
Why?
|
| DNA Methylation | 1 | 2019 | 44 | 0.150 |
Why?
|
| Academic Medical Centers | 1 | 2019 | 19 | 0.140 |
Why?
|
| Antibodies, Antinuclear | 2 | 2017 | 5 | 0.140 |
Why?
|
| Biomechanical Phenomena | 3 | 2010 | 95 | 0.130 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2017 | 11 | 0.130 |
Why?
|
| Surveys and Questionnaires | 2 | 2017 | 142 | 0.130 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2017 | 7 | 0.130 |
Why?
|
| Unnecessary Procedures | 1 | 2017 | 5 | 0.130 |
Why?
|
| Severity of Illness Index | 4 | 2015 | 97 | 0.130 |
Why?
|
| Weight-Bearing | 3 | 2010 | 21 | 0.110 |
Why?
|
| Patient Outcome Assessment | 1 | 2014 | 4 | 0.110 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 2014 | 2 | 0.100 |
Why?
|
| Immunoglobulin lambda-Chains | 1 | 2014 | 2 | 0.100 |
Why?
|
| Interleukin-10 | 1 | 2014 | 4 | 0.100 |
Why?
|
| Interferon-alpha | 1 | 2014 | 5 | 0.100 |
Why?
|
| Interleukin-6 | 1 | 2014 | 21 | 0.100 |
Why?
|
| Quality of Life | 2 | 2017 | 39 | 0.100 |
Why?
|
| Cultural Characteristics | 1 | 2013 | 3 | 0.100 |
Why?
|
| Cross-Sectional Studies | 2 | 2014 | 105 | 0.090 |
Why?
|
| Reproducibility of Results | 3 | 2017 | 83 | 0.090 |
Why?
|
| Psychometrics | 3 | 2017 | 27 | 0.080 |
Why?
|
| Cytokines | 1 | 2011 | 33 | 0.080 |
Why?
|
| Biomarkers | 1 | 2011 | 101 | 0.080 |
Why?
|
| Muscle Strength | 1 | 2010 | 6 | 0.080 |
Why?
|
| Pilot Projects | 1 | 2010 | 47 | 0.080 |
Why?
|
| Osteoarthritis, Hip | 2 | 2001 | 5 | 0.080 |
Why?
|
| Range of Motion, Articular | 2 | 2006 | 32 | 0.080 |
Why?
|
| Aged, 80 and over | 1 | 2010 | 567 | 0.070 |
Why?
|
| Activities of Daily Living | 1 | 2008 | 28 | 0.070 |
Why?
|
| Chi-Square Distribution | 1 | 2007 | 13 | 0.070 |
Why?
|
| Stress, Mechanical | 1 | 2007 | 36 | 0.070 |
Why?
|
| Radiography | 1 | 2007 | 53 | 0.070 |
Why?
|
| Longitudinal Studies | 2 | 2015 | 260 | 0.060 |
Why?
|
| Absorptiometry, Photon | 3 | 2006 | 22 | 0.060 |
Why?
|
| Exercise Test | 1 | 2006 | 6 | 0.060 |
Why?
|
| Autoantigens | 1 | 2006 | 2 | 0.060 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2006 | 7 | 0.060 |
Why?
|
| Reference Values | 1 | 2006 | 28 | 0.060 |
Why?
|
| Emotions | 2 | 2017 | 7 | 0.060 |
Why?
|
| Tibia | 1 | 2006 | 33 | 0.060 |
Why?
|
| Self Report | 2 | 2015 | 20 | 0.050 |
Why?
|
| Adaptation, Physiological | 1 | 2001 | 19 | 0.040 |
Why?
|
| Cartilage, Articular | 1 | 2001 | 70 | 0.040 |
Why?
|
| Analysis of Variance | 1 | 2000 | 30 | 0.040 |
Why?
|
| Autoimmune Diseases | 1 | 2019 | 7 | 0.040 |
Why?
|
| Gene Silencing | 1 | 2019 | 9 | 0.040 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2019 | 8 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 2019 | 13 | 0.040 |
Why?
|
| Flow Cytometry | 1 | 2019 | 23 | 0.040 |
Why?
|
| Hip | 1 | 1999 | 8 | 0.040 |
Why?
|
| Femur Neck | 1 | 1999 | 7 | 0.040 |
Why?
|
| Mentors | 1 | 2019 | 8 | 0.040 |
Why?
|
| Biomedical Research | 1 | 2019 | 12 | 0.040 |
Why?
|
| Teaching | 1 | 2019 | 14 | 0.040 |
Why?
|
| Faculty, Medical | 1 | 2019 | 27 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 174 | 0.030 |
Why?
|
| Mice | 1 | 2019 | 343 | 0.030 |
Why?
|
| Mental Health | 1 | 2017 | 8 | 0.030 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2017 | 6 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 50 | 0.030 |
Why?
|
| Health Care Surveys | 1 | 2017 | 14 | 0.030 |
Why?
|
| Blood Sedimentation | 1 | 2017 | 14 | 0.030 |
Why?
|
| Illinois | 1 | 2017 | 22 | 0.030 |
Why?
|
| Sleep | 1 | 2017 | 49 | 0.030 |
Why?
|
| Osteonecrosis | 1 | 2017 | 4 | 0.030 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2017 | 4 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2017 | 10 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2017 | 27 | 0.030 |
Why?
|
| Time Factors | 1 | 2017 | 208 | 0.030 |
Why?
|
| Software | 1 | 2015 | 8 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 85 | 0.030 |
Why?
|
| Physicians | 1 | 2015 | 15 | 0.030 |
Why?
|
| Body Image | 1 | 2014 | 3 | 0.030 |
Why?
|
| Goals | 1 | 2014 | 6 | 0.030 |
Why?
|
| Canada | 1 | 2014 | 7 | 0.030 |
Why?
|
| Language | 1 | 2014 | 12 | 0.030 |
Why?
|
| Philippines | 1 | 2013 | 3 | 0.020 |
Why?
|
| Cross-Cultural Comparison | 1 | 2013 | 6 | 0.020 |
Why?
|
| Cognition | 1 | 2014 | 220 | 0.020 |
Why?
|
| Young Adult | 1 | 2013 | 187 | 0.020 |
Why?
|
| Adolescent | 1 | 2013 | 247 | 0.020 |
Why?
|
| Metabolism | 1 | 2011 | 1 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 14 | 0.020 |
Why?
|
| Tissue Donors | 1 | 2011 | 10 | 0.020 |
Why?
|
| Arthrography | 1 | 2006 | 5 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2006 | 13 | 0.020 |
Why?
|
| Posture | 1 | 2006 | 8 | 0.020 |
Why?
|
| Movement | 1 | 2006 | 16 | 0.020 |
Why?
|
| Models, Anatomic | 1 | 2006 | 13 | 0.020 |
Why?
|
| Body Weight | 1 | 2006 | 34 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2006 | 64 | 0.010 |
Why?
|
| Lumbar Vertebrae | 1 | 1999 | 29 | 0.010 |
Why?
|